Skip to Content

Carbetapentane / diphenhydramine Pregnancy and Breastfeeding Warnings

Carbetapentane / diphenhydramine is also known as: D-Tann AT, Dytan-AT

Carbetapentane / diphenhydramine Pregnancy Warnings

Carbetapentane-diphenhydramine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Carbetapentane-diphenhydramine is only recommended for use during pregnancy when benefit outweighs risk.

See references

Carbetapentane / diphenhydramine Breastfeeding Warnings

There are no data on the excretion of carbetapentane-diphenhydramine into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. Dytan-AT (carbetapentane-diphenhydrAMINE)." Hawthorn Pharmaceuticals, Madison, MS.

References for breastfeeding information

  1. "Product Information. Dytan-AT (carbetapentane-diphenhydrAMINE)." Hawthorn Pharmaceuticals, Madison, MS.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide